Arkuda Therapeutics Email Format

Biotechnology ResearchMassachusetts, United States2-10 Employees

Arkuda Therapeutics is a small biotechnology company based in Watertown, Massachusetts, focused on neurodegenerative disease research. It pursues therapeutics by applying new understandings of progranulin biology and lysosomal function to influence the course of disease, with an emphasis on neuronal health. Positioned within the biotechnology research sector, the company aims to translate these scientific insights into medicines that could alter disease trajectories.

Evidence of its therapeutic focus includes work on frontotemporal dementia linked to progranulin. In 2025, Johnson & Johnson completed the acquisition of Arkuda Therapeutics, marking a major change in the company's corporate status.

Sign up for free to view info

Company overview Employee directory